Pnc Financial Services Group, Inc. Prometheus Biosciences, Inc. Transaction History

Pnc Financial Services Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$103.46 - $126.29 $234,750 - $286,552	2,269 Added 159.56%	3,691 $396,000
Q4 2022 Feb 10, 2023	BUY	$36.06 - $117.21 $43,993 - $142,996	1,220 Added 603.96%	1,422 $156,000
Q3 2022 Nov 10, 2022	BUY	$28.17 - $59.01 $2,929 - $6,137	104 Added 106.12%	202 $11,000
Q2 2022 Aug 12, 2022	BUY	$22.39 - $38.94 $2,194 - $3,816	98 New	98 $2,000

29.6K

Ticker RXDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,904,100
Description
Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases (IBD). Its lead product includes PRA023, a humanized IgG1 monoclonal antibody (mAb), which is in Phase IIa clinical trial...

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.